Duncan Barbara Gayle Insider Trades

Insider Trading History

Track insider trading activity for Duncan Barbara Gayle. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $1.7M 23,715 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 3,796 shares
$65.87
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $432k 6,040 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$398k 6,040 shares
$65.87
$71.60
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $161k 65,000 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 65,000 shares
$1.65
$2.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $277k 62,750 shares
Last Trade
Jun 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 29,600 shares
$3.25
$4.42
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $182k 41,200 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$134k 41,200 shares
$3.25
$4.42
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $0 0 shares
Last Trade
Jun 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 29,600 shares
$3.25
$4.42
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $1.43M 19,919 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$345k 5,750 shares
$60.03
$71.60
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $112k 45,000 shares
Last Trade
Feb 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.7k 45,000 shares
$0.57
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $223k 90,000 shares
Last Trade
Dec 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95.4k 90,000 shares
$1.06
$2.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $182k 41,200 shares
Last Trade
Jun 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 41,200 shares
$3.44
$4.42
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $147k 33,150 shares
Last Trade
Jun 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$120k 33,150 shares
$3.61
$4.42
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $0 0 shares
Last Trade
Jun 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$120k 33,150 shares
$3.61
$4.42
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
Director
Holding Value $0 0 shares
Last Trade
Jun 04, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.75M 81,000 shares
$21.55
$21.55
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $1.13M 15,754 shares
Last Trade
Apr 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$339k 8,804 shares
$38.46
$71.60
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $74.4k 30,000 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$110k 30,000 shares
$3.68
$2.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $207k 46,750 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$193k 46,750 shares
$4.12
$4.42
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
Director
Holding Value $366k 17,000 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.9k 17,000 shares
$4.64
$21.55
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $814k 11,371 shares
Last Trade
May 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 11,371 shares
$31.00
$71.60
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $0 0 shares
Last Trade
May 03, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$236k 125,761 shares
$1.88
$1.88
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $37.2k 15,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 15,000 shares
$2.50
$2.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up